FdL Medical: what changed
FdL Medical
Largest movements
- Current investments +€80,000
new in 2025: €80,000
- Cash -€25,288
down €25,288 (-24.5%), from €103,049 to €77,762
mainly Current investments (-€80,000) and Debts after one year (-€5,525)
- Tangible fixed assets -€5,418
down €5,418 (-29.0%), from €18,688 to €13,270
- Deferred charges and accrued income -€1,967
down €1,967 (-69.9%), from €2,812 to €845
- Profit (loss) carried forward +€54,503
up €54,503 (+64.9%), from €83,989 to €138,491
- Debts after one year -€5,525
down €5,525 (-40.3%), from €13,695 to €8,171
- Tax, wage and social debts -€2,861
down €2,861 (-14.2%), from €20,177 to €17,316
- Gross operating margin -€9,715
down €9,715 (-11.2%), from €86,700 to €76,985
- Taxes -€2,031
down €2,031 (-12.1%), from €16,716 to €14,686
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €124,912 | €171,877 | +€46,964 | +37.6% |
| Fixed assets | 21/28 | €18,688 | €13,270 | -€5,418 | -29.0% |
| Tangible fixed assets | 22/27 | €18,688 | €13,270 | -€5,418 | -29.0% |
| Leasing and similar rights | 25 | €18,688 | €13,270 | -€5,418 | -29.0% |
| Current assets | 29/58 | €106,225 | €158,607 | +€52,382 | +49.3% |
| Amounts receivable within one year | 40/41 | €364 | - | -€364 | |
| Other amounts receivable | 41 | €364 | - | -€364 | |
| Current investments | 50/53 | - | €80,000 | +€80,000 | |
| Cash at bank and in hand | 54/58 | €103,049 | €77,762 | -€25,288 | -24.5% |
| Deferred charges and accrued income | 490/1 | €2,812 | €845 | -€1,967 | -69.9% |
| Total equity and liabilities | 10/49 | €124,912 | €171,877 | +€46,964 | +37.6% |
| Equity | 10/15 | €84,089 | €138,591 | +€54,503 | +64.8% |
| Contributions | 10/11 | €100 | €100 | = | 0.0% |
| Profit (loss) carried forward | 14 | €83,989 | €138,491 | +€54,503 | +64.9% |
| Amounts payable | 17/49 | €40,824 | €33,286 | -€7,538 | -18.5% |
| Amounts payable after more than one year | 17 | €13,695 | €8,171 | -€5,525 | -40.3% |
| Financial debts | 170/4 | €13,695 | €8,171 | -€5,525 | -40.3% |
| Amounts payable within one year | 42/48 | €27,129 | €25,115 | -€2,014 | -7.4% |
| Current portion of amounts payable after more than one year | 42 | €5,331 | €5,525 | +€193 | +3.6% |
| Trade debts | 44 | €787 | €795 | +€7 | +0.9% |
| Suppliers | 440/4 | €787 | €795 | +€7 | +0.9% |
| Taxes, remuneration and social security | 45 | €20,177 | €17,316 | -€2,861 | -14.2% |
| Taxes | 450/3 | €20,177 | €17,316 | -€2,861 | -14.2% |
| Other amounts payable | 47/48 | €833 | €1,480 | +€647 | +77.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,418 | €5,418 | = | 0.0% |
| Other operating charges | 640/8 | €1,792 | €1,716 | -€76 | -4.2% |
| Gross operating margin | 9900 | €86,700 | €76,985 | -€9,715 | -11.2% |
| Operating profit (loss) | 9901 | €79,490 | €69,851 | -€9,640 | -12.1% |
| Financial charges | 65/66B | €847 | €662 | -€185 | -21.8% |
| Recurring financial charges | 65 | €847 | €662 | -€185 | -21.8% |
| Profit (loss) for the period before taxes | 9903 | €78,643 | €69,188 | -€9,455 | -12.0% |
| Income taxes | 67/77 | €16,716 | €14,686 | -€2,031 | -12.1% |
| Profit (loss) for the period | 9904 | €61,927 | €54,503 | -€7,424 | -12.0% |
| Profit (loss) for the period to be appropriated | 9905 | €61,927 | €54,503 | -€7,424 | -12.0% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.